GeneASIC Technologies Corporation
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
GeneASIC Technologies Corporation NGSAAP Next-Generation Sequencing Analysis Acceleration Platform. GeneASIC Technologies Corporation's NGSAAP is an ultra-high-speed NGS data analysis solution. It miniaturizes the tedious sequencing analysis workflow into a compact footprint while ensuring analytical accuracy. Fully localized computing ensures data security and privacy. The system supports direct, real-time access to genotype data, significantly saving data transmission time between end-users and cloud servers. Regardless of the type of genetic sequencing, GeneASIC Technologies Corporation's NGSAAP helps anyone, anywhere, fully harness the power of genomics.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83112261
Status
Active
Number of Employees
11
Total Paid-in
Capital
6,566,626 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
GeneASIC Technologies Corporation is a startup company based on technology transfers from laboratories at National Taiwan University and National Yang Ming Chiao Tung University, and co-invested by the listed company AP Memory Technology Corporation and others. It primarily combines expertise in bioinformatics and electronic chip design to provide SoC (System-on-Chip) solutions for whole-genome analysis, and is dedicated to supporting research or applications in personalized medicine, achieving real-time gene sequencing anywhere, and precision medicine.
(The content above was translated by AI.)
(The content above was translated by AI.)
